Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Recursion Pharmaceuticals Inc Cl A (NQ: RXRX ) 7.242 -0.168 (-2.26%) Streaming Delayed Price Updated: 1:19 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,608,807 Open 7.530 Bid (Size) 7.240 (7) Ask (Size) 7.250 (335) Prev. Close 7.410 Today's Range 7.195 - 7.600 52wk Range 4.970 - 15.74 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Is Recursion Pharmaceuticals a Warren Buffett Stock? Today 4:10 EDT Don't expect Buffett to invest in this stock tomorrow, but it has the potential to eventually be a stock he would consider. Via The Motley Fool Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week August 27, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030. Via Talk Markets Performance YTD -26.62% -26.62% 1 Month -8.90% -8.90% 3 Month -18.35% -18.35% 6 Month -46.19% -46.19% 1 Year -17.70% -17.70% More News Read More How Is The Market Feeling About Recursion Pharmaceuticals? August 23, 2024 Via Benzinga The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why. August 18, 2024 Via The Motley Fool Is Recursion Pharmaceuticals Stock a Buy? August 17, 2024 Via The Motley Fool AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD August 14, 2024 Via Talk Markets Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT August 08, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th August 05, 2024 From Recursion Pharmaceuticals Via GlobeNewswire How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates August 14, 2024 Via FinancialNewsMedia Topics Artificial Intelligence Exposures Artificial Intelligence How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates August 14, 2024 From FN Media Group LLC Via GlobeNewswire Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks August 13, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RXRX, GVP, OBDE, OBDC on Behalf of Shareholders August 12, 2024 From Halper Sadeh LLC Via GlobeNewswire Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move August 12, 2024 Via The Motley Fool Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia? August 11, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals August 08, 2024 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence RXRX Stock Earnings: Recursion Pharmaceuticals Meets EPS, Beats Revenue for Q2 2024 August 08, 2024 Via InvestorPlace CORRECTION - Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results August 08, 2024 From Recursion Pharmaceuticals Via GlobeNewswire RXRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Recursion Pharmaceuticals, Inc. Is Fair to Shareholders August 08, 2024 From Halper Sadeh LLC Via Business Wire Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities August 08, 2024 From Recursion Pharmaceuticals, Inc. Via GlobeNewswire Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results August 08, 2024 From Recursion Pharmaceuticals Via GlobeNewswire Is Recursion Pharmaceuticals a Millionaire-Maker? August 06, 2024 Via The Motley Fool 99.9% of Nvidia's $380 Million Investment Portfolio Has Been Put to Work in These 4 Artificial Intelligence (AI)-Inspired Stocks July 31, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD July 30, 2024 Via Talk Markets Down About 47% This Year: Is Recursion Pharmaceuticals a Buy on the Dip? July 27, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence 25 Best Artificial Intelligence Stocks to Buy Right Now July 25, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
